Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

VEGFA anticorps (Isoform 165)

VEGFA Reactivité: Humain WB, EIA, Func Hôte: Souris Monoclonal 3 unconjugated
N° du produit ABIN155173
  • Antigène Voir toutes VEGFA Anticorps
    VEGFA (Vascular Endothelial Growth Factor A (VEGFA))
    Épitope
    • 19
    • 15
    • 15
    • 15
    • 15
    • 15
    • 10
    • 7
    • 7
    • 6
    • 6
    • 6
    • 6
    • 5
    • 5
    • 5
    • 4
    • 4
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Isoform 165
    Reactivité
    • 154
    • 126
    • 99
    • 24
    • 20
    • 19
    • 19
    • 16
    • 12
    • 7
    • 5
    • 5
    • 4
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 204
    • 52
    • 13
    • 1
    • 1
    Souris
    Clonalité
    • 215
    • 55
    • 1
    Monoclonal
    Conjugué
    • 122
    • 41
    • 25
    • 12
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 4
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp VEGFA est non-conjugé
    Application
    • 205
    • 93
    • 65
    • 65
    • 51
    • 32
    • 27
    • 22
    • 22
    • 15
    • 15
    • 12
    • 10
    • 9
    • 7
    • 7
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), Enzyme Immunoassay (EIA), Functional Studies (Func)
    Specificité
    The antibody recognizes VEGF-A.
    Réactivité croisée (Details)
    Species reactivity (tested):Human.
    Purification
    Protein G Chromatography
    Immunogène
    Recombinant Human VEGF165 protein (45 kDa)
    Clone
    3
    Isotype
    IgG1
    Top Product
    Discover our top product VEGFA Anticorps primaire
  • Indications d'application
    ELISA: 1-15 μg/mL. Western blot: 2-10 μg/mL. Neutralization: Blocks the VEGF-A induced proliferation of ACE cell at a 1: 6 Molar ratio ofligand to antibody. Inhibits the binding of VEGF-A to the VEGF receptors 1 (Flt-1) and 2 (KDR).
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.
    Restrictions
    For Research Use only
  • Reconstitution
    Restore in sterile water to a concentration of 0.1-1.0 mg/mL.
    Buffer
    H2O, Trehalose, Na-Phosphate, Polysorbart20
    Conseil sur la manipulation
    Avoid repeated freezing and thawing.
    Stock
    4 °C/-20 °C
    Stockage commentaire
    The lyophilized antibody, thought stable at RT, is best stored desiccated below 0 °C. Reconstituted anti-VEGF-A is stable at 2-8 °C for one month or (in aliquots) at - 20 °C for longer.
  • Antigène
    VEGFA (Vascular Endothelial Growth Factor A (VEGFA))
    Autre désignation
    VEGF-A (VEGFA Produits)
    Synonymes
    anticorps MVCD1, anticorps VEGF, anticorps VPF, anticorps Vegf, anticorps Vegf120, anticorps Vegf164, anticorps Vegf188, anticorps Vpf, anticorps vegf, anticorps vegfa, anticorps wu:fj82c06, anticorps VEGF-A, anticorps VEGF164, anticorps eVEGF120, anticorps eVEGF164, anticorps vegf-a, anticorps vpf, anticorps vefg, anticorps si:dkey-14d8.3, anticorps wu:fd42e02, anticorps vascular endothelial growth factor A, anticorps vascular endothelial growth factor Aa, anticorps vascular endothelial growth factor A L homeolog, anticorps vascular endothelial growth factor Ab, anticorps VEGFA, anticorps Vegfa, anticorps vegfaa, anticorps vegfa.L, anticorps vegfa, anticorps vegfab
    Sujet
    Human Vascular Endothelial Growth Factor VEGF165, a 23 kDa protein consisting of 165 amino acid residues, is produced as a homodimer. VEGF is a polypeptide growth factor and a member of the platelet-derived growth factor family. It is a specific mitogen for vascular endothelial cells and a strong angiogenic factor in vivo. Two high-affinity tyrosine kinase receptors for VEGF165 have been identified, VEGFR-1 (FLT-1), and VEGFR-2 (KDR). In addition to its action as a mitogen it is a potent vascular permeability factor (VPF) in vivo. VEGF165 is also a chemo attractant molecule for monocytes and endothelial cells. 5 different proteins are generated by differential splicing: VEGF121, VEGF145, VEGF165, VEGF189 and VEGF206. The most abundant form is VEGF165. Whereas VEGF121 and VEGF165 are secreted proteins, VEGF145, VEGF189 and VEGF206 are strongly cell-associated. The isoforms VEGF145, VEGF165 and VEGF189 bind to heparin with high affinity. VEGF165 is apparently a homo-dimer, but preparations of VEGF165 show some heterogeneity on SDS gels, depending on the secretion of different glycosylation patterns. All dimeric forms have similar biological activities but their bioavailability is very different. There is good evidence that different cells and tissues express different VEGF isoforms. The other members of this increasing growth factor family are VEGF-B, -C, -D and -E. Another member is the Placenta growth factor PlGF.Synonyms: VEGF, VEGFA, VPF, Vascular endothelial growth factor A, Vascular permeability factor
    ID gène
    7422
    NCBI Accession
    NP_001020537
    UniProt
    P15692
    Pathways
    Signalisation RTK, Glycosaminoglycan Metabolic Process, Regulation of Cell Size, Tube Formation, Signaling Events mediated by VEGFR1 and VEGFR2, Platelet-derived growth Factor Receptor Signaling, VEGFR1 Specific Signals, VEGF Signaling
Vous êtes ici:
Support technique